CTRI/2022/12/048036尚未招募4 期
Effectiveness of Low Molecular Weight Heparin in reduction ofseverity of inflammation in patients with Acute Pancreatitis-A Randomized Controlled Trial
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients >18 years diagnosed with acute moderate
- •and severe pancreatitis as per the revised Atlanta classification.
排除标准
- •-Duration of symptoms for more than 7 days.
- •-Hypersensitivity to LMWH or radiocontrast agents
- •-Pregnant or breastfeeding
- •-Patients in coagulopathy (INR)
- •-patients with Chronic liver disease (USG Liver)
- •- Patients with thrombocytopenia (BT/CT)
- •-Patients with diabetic nephropathy (Urine PCR)
- •-Patients on ACE inhibitors/aldosterone receptor antagonists
- •-Diagnosed with hemorrhagic pancreatitis/pseudoaneurysm in imaging
研究者
相似试验
进行中（未招募）
1 期
ow-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different dosesPrevention of thromboembolic events in hospitalised COVID-19 infected patientsMedDRA version: 20.0Level: HLGTClassification code 10014523Term: Embolism and thrombosisSystem Organ Class: 10047065 - Vascular disordersEUCTR2020-001709-21-FRCHRU de Nancy550
已完成
不适用
Effectiveness of low-molecular-weight heparin for prevention of deep venous thrombosis after surgery for colorectal cancer in Japanese patients: a randomized controlled phase III trialcolorectal cancerJPRN-UMIN000030582Tokyo Metropolitan Hiroo Hospital160
已完成
4 期
Highlow study: Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two dosespulmonary embolismNL-OMON55412Academisch Medisch Centrum200
进行中（未招募）
1 期
Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)COVID-19EUCTR2020-001891-14-ESFundación Neumosur140
已完成
不适用
Inhalation of Low Molecular Weight Heparins as a prophylaxis to prevent SARS-CoV-2 infectioNL-OMON50776Academisch Medisch Centrum28